Opiods

Prime Theraputics

Opioid registry, predictive modeling help identify at-risk Medicare members in Florida (Eagan, MN) — July 18, 2022  — During the COVID-19 pandemic, drug overdoses killed over 107,000 Americans in 2021.1 Prior to the pandemic, Prime Therapeutics LLC (Prime), a leading pharmacy benefit manager (PBM) serving nearly 33 million members nationally, began an intervention program targeting Medicare members who were at high risk of overutilizing opioids. A pilot with Medicare members of GuideWell